Peptides
The Next GLP-1 Wave: Oral Pills, Dual Agonists, and Nanofiber Depots
Weekly semaglutide rewrote metabolic medicine. The pipeline behind it — a small-molecule pill, a twin-receptor agonist, and an injectable depot that lasts weeks — is now coming into focus.